Aviva
LEGN icon

Aviva’s Legend Biotech LEGN Stock Holding History

Aviva’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Sell
53,486
-627
-1% -$16.9K ﹤0.01% 629
2026
Q1 		$979K Buy
54,113
+1,369
+3% +$26.1K ﹤0.01% 643
2025
Q4 		$1.15M Sell
52,744
-1,508
-3% -$43.2K ﹤0.01% 654
2025
Q3 		$1.77M Buy
54,252
+8,062
+17% +$298K ﹤0.01% 641
2025
Q2 		$1.64M Sell
46,190
-2,959
-6% -$95.9K ﹤0.01% 643
2025
Q1 		$1.67M Buy
49,149
+849
+2% +$30.4K ﹤0.01% 590
2024
Q4 		$1.57M Buy
48,300
+1,700
+4% +$70.4K ﹤0.01% 607
2024
Q3 		$2.27M Sell
46,600
-400
-0.9% -$21.3K 0.01% 537
2024
Q2 		$2.08M Hold
47,000
– – 0.01% 576
2024
Q1 		$2.64M Buy
47,000
+3,000
+7% +$181K 0.01% 564
2023
Q4 		$2.65M Buy
44,000
+8,100
+23% +$513K 0.01% 568
2023
Q3 		$2.41M Hold
35,900
– – 0.01% 596
2023
Q2 		$2.48M Buy
35,900
+2,100
+6% +$137K 0.01% 596
2023
Q1 		$1.63M Buy
33,800
+5,000
+17% +$245K 0.01% 697
2022
Q4 		$1.44M Buy
28,800
+2,300
+9% +$111K 0.01% 745
2022
Q3 		$1.08M Buy
26,500
+2,900
+12% +$136K 0.01% 903
2022
Q2 		$1.3M Buy
23,600
+3,400
+17% +$144K 0.01% 933
2022
Q1 		$734K Buy
20,200
+3,600
+22% +$142K ﹤0.01% 998
2021
Q4 		$774K Buy
+16,600
New +$842K ﹤0.01% 956

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Aviva's LEGN Position: Q2 2026 in Review

Aviva reduced its Legend Biotech (LEGN) stake by 1.2% in Q2 2026, selling an estimated $16.9K and leaving 53,486 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #629.

Aviva first reported a position in LEGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.65M in Q4 2023. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Aviva held 53,486 shares of Legend Biotech worth $1.54M as of Q2 2026.
  • Aviva sold 627 Legend Biotech shares in Q2 2026, an estimated $16.9K.
  • Legend Biotech made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #629 holding.
  • Aviva first reported a position in Legend Biotech in Q4 2021 and has held it in 19 quarters since.
  • Aviva's Legend Biotech position peaked at $2.65M in Q4 2023.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.